Augmenix's Series E Round

Augmenix raised a round of funding on July 13, 2016.

Augmenix is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Augmenix's initial product wi…

Articles about Augmenix's Series E Round: